Y-Intercept (HK)
TMCI icon

Y-Intercept (HK)’s Treace Medical Concepts TMCI Stock Holding History

Y-Intercept (HK)’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$72.8K Buy
+16,405
New +$73.6K ﹤0.01% 1518
2025
Q3 		– Sell
-232,413
Closed -$1.37M – 2050
2025
Q2 		$1.37M Buy
232,413
+201,252
+646% +$1.31M 0.03% 785
2025
Q1 		$261K Buy
+31,161
New +$280K 0.02% 951
2024
Q3 		– Sell
-96,317
Closed -$641K – 1803
2024
Q2 		$641K Buy
96,317
+45,091
+88% +$364K 0.04% 712
2024
Q1 		$668K Buy
+51,226
New +$683K 0.05% 562
2023
Q4 		– Sell
-25,464
Closed -$334K – 1643
2023
Q3 		$334K Buy
+25,464
New +$466K 0.03% 720

Other funds holding TMCI

Gagnon Securities
Gagnon Securities New York $577M AUM 61.61% 1-Year Est. Return
GA
Gagnon Advisors New York $182M AUM 52.04% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Weber Capital Management
Weber Capital Management San Francisco, California $110M AUM 43.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
LS
LCW Services Virginia Beach, Virginia $240M AUM 12.93% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Y-Intercept (HK)'s TMCI Position: Q3 2026 in Review

Y-Intercept (HK) opened a new position in Treace Medical Concepts (TMCI) in Q3 2026: 16,405 shares worth $72.8K. The stake represents ﹤0.01% of the portfolio and ranks #1518 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in TMCI as recently as Q2 2025.

Y-Intercept (HK) first reported a position in TMCI in Q3 2023 and has held it in 6 quarters since. The position peaked at $1.37M in Q2 2025. 51 funds tracked by Wall St. Rank hold TMCI as of Q3 2026.

  • Y-Intercept (HK) held 16,405 shares of Treace Medical Concepts worth $72.8K as of Q3 2026.
  • Treace Medical Concepts was a new Y-Intercept (HK) position in Q3 2026.
  • Treace Medical Concepts made up ﹤0.01% of Y-Intercept (HK)'s portfolio in Q3 2026, its #1518 holding.
  • Y-Intercept (HK) first reported a position in Treace Medical Concepts in Q3 2023 and has held it in 6 quarters since.
  • Y-Intercept (HK)'s Treace Medical Concepts position peaked at $1.37M in Q2 2025.
  • 51 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.